Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
28.03.24
/
50%
€2.04
Target price
28.03.25
€4.62
Performance (%)
-16.08%
Price
13.05.24
€1.76
Summary
This prediction is currently active. The prediction for Xeris Biopharma Holdings Inc. disappoints with a performance of -16.08%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | -0.170% | -0.170% |
iShares Core DAX® | 1.662% | 4.835% |
iShares Nasdaq 100 | 0.667% | 0.000% |
iShares Nikkei 225® | -2.139% | -4.786% |
iShares S&P 500 | 0.564% | 0.775% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
Ratings data for XERS provided by MarketBeat